| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Annexon, Inc. | Director | Stock Option (Right to Buy) | 55,000 | 05 Jun 2025 | Direct | ||
| CNS Pharmaceuticals, Inc. | Director | Option to purchase common stock | 1,517 | 17 Nov 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CNSP | CNS Pharmaceuticals, Inc. | 17 Nov 2025 | 1 | $0 | 4 | Director | 19 Nov 2025, 17:00 |
| ANNX | Annexon, Inc. | 05 Jun 2025 | 1 | $0 | 4 | Director | 09 Jun 2025, 16:16 |
| ANNX | Annexon, Inc. | 05 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 21:40 |
| CNSP | CNS Pharmaceuticals, Inc. | 08 Apr 2024 | 2 | $0 | 4 | Director | 10 Apr 2024, 21:51 |
| CNSP | CNS Pharmaceuticals, Inc. | 21 Sep 2023 | 1 | $0 | 4 | Director | 25 Sep 2023, 18:21 |
| CNSP | CNS Pharmaceuticals, Inc. | 14 Sep 2023 | 2 | $0 | 4/A | Director | 12 Oct 2023, 18:00 |
| ANNX | Annexon, Inc. | 08 Jun 2023 | 1 | $0 | 4 | Director | 12 Jun 2023, 16:48 |
| CNSP | CNS Pharmaceuticals, Inc. | 05 May 2023 | 1 | $0 | 4/A | Director | 10 Aug 2023, 21:14 |
| CNSP | CNS Pharmaceuticals, Inc. | 03 May 2023 | 0 | $0 | 3 | Director | 09 May 2023, 17:10 |
| ANNX | Annexon, Inc. | 09 Jun 2022 | 1 | $0 | 4 | Director | 13 Jun 2022, 16:36 |
| ANNX | Annexon, Inc. | 19 Jan 2022 | 1 | $0 | 4 | Director | 20 Jan 2022, 16:06 |
| ANNX | Annexon, Inc. | 19 Jan 2022 | 0 | $0 | 3 | Director | 20 Jan 2022, 16:05 |